Restoring the Hb to normal levels in patients with ESRD on hemodialysis may be associated with an improvement in quality of life and regression of LVH but possibly at the expense of serious cardiovascular outcomes, particularly among those in whom anemia is more difficult to correct [10]. This evidence concerns the gene GSTM1 and anemia.